Innes Kim E, Bourguignon Cheryl, Taylor Ann Gill
Center for the Study of Complementary and Alternative Therapies, Blake Center, PO Box 800905, University of Virginia Health Systems, Charlottesville, VA 22908-0905, USA.
J Am Board Fam Pract. 2005 Nov-Dec;18(6):491-519. doi: 10.3122/jabfm.18.6.491.
To conduct a systematic review of published literature regarding the effects of yoga, a promising mind-body therapy, on specific anthropometric and physiologic indices of cardiovascular disease (CVD) risk and on related clinical endpoints.
We performed a literature search using 4 computerized English and Indian scientific databases. The search was restricted to original studies (1970 to 2004) evaluating the effects of yoga on CVD or indices of CVD risk associated with the insulin resistance syndrome (IRS). Randomized controlled trials (RCTs), nonrandomized controlled trials, uncontrolled (pre and post) clinical trials, and cross-sectional (observational) studies were included if they met specific criteria. Data were extracted regarding study design, setting, population size and characteristics, intervention type and duration, comparison group or condition, outcome assessment, data analysis and presentation, follow-up, and key results, and the quality of each study was evaluated according to specific predetermined criteria.
We identified 70 eligible studies, including 1 observational study, 26 uncontrolled clinical trials, 21 nonrandomized controlled clinical trials, and 22 RCTs. Together, the reported results of these studies indicate beneficial changes overall in several IRS-related indices of CVD risk, including glucose tolerance and insulin sensitivity, lipid profiles, anthropometric characteristics, blood pressure, oxidative stress, coagulation profiles, sympathetic activation, and cardiovagal function, as well as improvement in several clinical endpoints.
Collectively, these studies suggest that yoga may reduce many IRS-related risk factors for CVD, may improve clinical outcomes, and may aid in the management of CVD and other IRS-related conditions. However, the methodologic and other limitations characterizing most of these studies preclude drawing firm conclusions. Additional high quality RCTs are needed to confirm and further elucidate the effects of standardized yoga programs on specific indices of CVD risk and related clinical endpoints.
对已发表的有关瑜伽(一种有前景的身心疗法)对心血管疾病(CVD)风险的特定人体测量和生理指标以及相关临床终点影响的文献进行系统综述。
我们使用4个计算机化的英文和印度科学数据库进行文献检索。检索限于评估瑜伽对CVD或与胰岛素抵抗综合征(IRS)相关的CVD风险指标影响的原始研究(1970年至2004年)。如果符合特定标准,则纳入随机对照试验(RCT)、非随机对照试验、非对照(前后)临床试验和横断面(观察性)研究。提取有关研究设计、背景、人群规模和特征、干预类型和持续时间、比较组或条件、结果评估、数据分析和呈现、随访以及关键结果的数据,并根据特定的预定标准评估每项研究的质量。
我们确定了70项符合条件的研究,包括1项观察性研究、26项非对照临床试验、21项非随机对照临床试验和22项RCT。总体而言,这些研究报告的结果表明,在几个与IRS相关的CVD风险指标方面总体上有有益变化,包括糖耐量和胰岛素敏感性、血脂谱、人体测量特征、血压、氧化应激、凝血谱、交感神经激活和心迷走神经功能,以及几个临床终点的改善。
总体而言,这些研究表明瑜伽可能会降低许多与IRS相关的CVD风险因素,可能改善临床结果,并可能有助于管理CVD和其他与IRS相关的疾病。然而,这些研究大多存在的方法学和其他局限性妨碍了得出确凿结论。需要更多高质量的RCT来证实并进一步阐明标准化瑜伽项目对CVD风险特定指标和相关临床终点的影响。